Control of von Willebrand factor multimer size by thrombospondin-1

被引:108
作者
Xie, LJ
Chesterman, CN
Hogg, PJ [1 ]
机构
[1] Univ New S Wales, Sch Pathol, Ctr Thrombosis & Vasc Res, Sydney, NSW 2052, Australia
[2] Prince Wales Hosp, Dept Haematol, Sydney, NSW 2052, Australia
关键词
endothelial cell; reductase; disulfide; thrombosis; hemostasis;
D O I
10.1084/jem.193.12.1341
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Plasma von Willebrand factor (VWF) is a multimeric protein that mediates adhesion of platelets to sites of vascular injury. Only the very large VWF multimers are effective in promoting plate let adhesion in flowing blood. A protein disulfide bond reductase in plasma reduces the average multimer size of vWF secreted by endothelial cells. This activity has been isolated from human endothelial cell conditioned medium and shown to be the trimeric glycoprotein, thrombospondin-1 (TSP-1). Incubation of purified TSP-1 with vWF resulted in formation of thiol-dependent complexes of TSP-1 and vWF, generation of new thiols in vWF, and reduction in the average multimer size of vWF. The ratio of the concentrations of TSP-1 and vWF in plasma reflected with average multimer size of vWF. The higher the plasma TSP-1/vWF molar ratio, the smaller the average vWF multimer size. In addition, administration of TSP-1 to mice resulted in reduction in the average multimer size of plasma vWF. Interaction of TSP-1 with vWF is mediated by TSP-1 type 1 properdin domains and the vWF A3 domain. These results indicate that TSP-1 regulates the multimeric size and therefore hemostatic activity of vWF.
引用
收藏
页码:1341 / 1349
页数:9
相关论文
共 38 条
  • [1] HMEC-1 - ESTABLISHMENT OF AN IMMORTALIZED HUMAN MICROVASCULAR ENDOTHELIAL-CELL LINE
    ADES, EW
    CANDAL, FJ
    SWERLICK, RA
    GEORGE, VG
    SUMMERS, S
    BOSSE, DC
    LAWLEY, TJ
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (06) : 683 - 690
  • [2] THROMBOSPONDIN SEQUENCE MOTIF (CSVTCG) IS RESPONSIBLE FOR CD36-BINDING
    ASCH, AS
    SILBIGER, S
    HEIMER, E
    NACHMAN, RL
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 182 (03) : 1208 - 1217
  • [3] ANALYSIS OF CD36 BINDING DOMAINS - LIGAND SPECIFICITY CONTROLLED BY DEPHOSPHORYLATION OF AN ECTODOMAIN
    ASCH, AS
    LIU, I
    BRICCETTI, FM
    BARNWELL, JW
    KWAKYEBERKO, F
    DOKUN, A
    GOLDBERGER, J
    PERNAMBUCO, M
    [J]. SCIENCE, 1993, 262 (5138) : 1436 - 1440
  • [4] RISTOCETIN-DEPENDENT RECONSTITUTION OF BINDING OF VONWILLEBRAND-FACTOR TO PURIFIED HUMAN-PLATELET MEMBRANE GLYCOPROTEIN IB-IX COMPLEX
    BERNDT, MC
    DU, XP
    BOOTH, WJ
    [J]. BIOCHEMISTRY, 1988, 27 (02) : 633 - 640
  • [5] FACTOR-VIII/VONWILLEBRAND FACTOR HAS POTENT LECTIN ACTIVITY
    BOOTH, WJ
    FURBY, FH
    BERNDT, MC
    CASTALDI, PA
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 118 (02) : 495 - 501
  • [6] Quantitative analysis of von Willebrand factor propeptide release in vivo: Effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans
    Borchiellini, A
    Fijnvandraat, K
    tenCate, JW
    Pajkrt, D
    vanDeventer, SJH
    Pasterkamp, G
    MeijerHuizinga, F
    ZwartHuinink, L
    Voorberg, J
    vanMourik, JA
    [J]. BLOOD, 1996, 88 (08) : 2951 - 2958
  • [7] DISULFIDE BONDS AND QUATERNARY STRUCTURE OF FACTOR-VIII-VONWILLEBRAND FACTOR
    COUNTS, RB
    PASKELL, SL
    ELGEE, SK
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1978, 62 (03) : 702 - 709
  • [8] DONG ZG, 1994, J BIOL CHEM, V269, P6753
  • [9] DEVELOPMENT OF A SIMPLE COLLAGEN BASED ELISA ASSAY AIDS IN THE DIAGNOSIS OF, AND PERMITS SENSITIVE DISCRIMINATION BETWEEN TYPE-I AND TYPE-II, VONWILLEBRANDS DISEASE
    FAVALORO, EJ
    GRISPO, L
    EXNER, T
    KOUTTS, J
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1991, 2 (02) : 285 - 291
  • [10] The protein disulphide-isomerase family:: unravelling a string of folds
    Ferrari, DM
    Söling, HD
    [J]. BIOCHEMICAL JOURNAL, 1999, 339 : 1 - 10